(Reuters) – U.S. drugmaker Eli Lilly expects its blockbuster weight-loss drug to officially come out of shortage in the United States in coming days, Bloomberg News reported on Thursday, citing an interview with the company’s CEO, David Ricks. Lilly’s drug, tirzepatide, sold as Mounjaro for diabetes and Zepbound for weight management, will cease to be…
By Mathieu Rosemain PARIS (Reuters) – BNP Paribas is in exclusive talks with French insurer AXA to buy 100% of its AXA Investment Managers arm at an agreed price of 5.1 billion euros ($5.50 billion), the euro zone’s biggest bank said on Thursday. For BNP, such an acquisition would significantly boost its asset management arm…
(Reuters) – Global mega tech companies’ market capitalisation dropped sharply in July, in response to disappointing quarterly results and concerns over high valuations, prompting investors to shift their focus away from the AI sector. In the first half of 2024, investors pushed tech stocks higher on expectations that AI advancements would boost earnings. But the…
By Shivansh Tiwary and Rajesh Kumar Singh (Reuters) -Spirit Airlines on Thursday warned of a steeper loss in the current quarter, citing an “intense competitive battle” for the price-sensitive leisure travelers as well as an oversupply of airline seats in the domestic market. The airline has failed to report a profit in the last five…
